Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Pharmacogenetics, Therapeutic Drug Monitoring (TDM) and Active Pharmacovigilance as Innovative Tools Aimed at the Optimisation/ Appropriateness of Drug Therapy and the Minimisation of the Risks of ADRs in Clinical Practice: a Multidisciplinary Approach Exportable at National Level

NCT06822959 is registered in ClinicalTrials.gov with Direzione centrale salute, politiche sociali e disabilità as lead sponsor.

NCT NCT06822959
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06822959 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Pharmacogenetics, Therapeutic Drug Monitoring (TDM) and Active Pharmacovigilance as Innovative Tools Aimed at the Optimisation/ Appropriateness of Drug Therapy and the Minimisation of the Risks of ADRs in Clinical Practice: a Multidisciplinary Approach Exportable at National Level
Lead sponsor
Direzione centrale salute, politiche sociali e disabilità
Phase
Observational
Overall status
Active, not recruiting
Start date
June 10, 2022
Completion date
October 31, 2026
Enrollment
450 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

adverse drug reaction (adr)